| Targeted drug delivery using genetically engineered diatom biosilica B Delalat, VC Sheppard, SR Ghaemi, S Rao, CA Prestidge, G McPhee, ... Nature Communications 6 (8791), doi: 10.1038/ncomms9791, 2015 | 285 | 2015 |
| Isolation and enrichment of embryonic mouse motoneurons from the lumbar spinal cord of individual mouse embryos S Wiese, T Herrmann, C Drepper, S Jablonka, N Funk, A Klausmeyer, ... Nature protocols 5 (1), 31-38, 2010 | 137 | 2010 |
| Drug Delivery: Antibody‐Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs (Adv. Healthcare Mater. 5/2013) E Secret, K Smith, V Dubljevic, E Moore, P Macardle, B Delalat, ... Advanced Healthcare Materials 2 (5), 626-626, 2013 | 133* | 2013 |
| Urinary p75ECD A prognostic, disease progression, and pharmacodynamic biomarker in ALS SR Shepheard, J Wuu, M Cardoso, L Wiklendt, PG Dinning, T Chataway, ... Neurology 88 (12), 1137-1143, 2017 | 107 | 2017 |
| Porous Silicon Nanodiscs for Targeted Drug Delivery H Alhmoud, B Delalat, R Elnathan, A Cifuentes-Rius, A Chaix, ML Rogers, ... Advanced Functional Materials 25 (7), 1137-1145, 2015 | 99 | 2015 |
| Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells DA Belford, ML Rogers, GO Regester, GL Francis, GW Smithers, IJ Liepe, ... In Vitro Cellular & Developmental Biology-Animal 31, 752-760, 1995 | 88 | 1995 |
| Transforming growth factor β in bovine milk: concentration, stability and molecular mass forms ML Rogers, C Goddard, GO Regester, FJ Ballard, DA Belford Journal of Endocrinology 151 (1), 77-86, 1996 | 86 | 1996 |
| Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery ML Rogers, RA Rush Journal of controlled release 157 (2), 183-189, 2012 | 85 | 2012 |
| The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis SR Shepheard, T Chataway, DW Schultz, RA Rush, ML Rogers PLoS One 9 (1), e87398, 2014 | 72 | 2014 |
| Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial Amyotroph Lateral Scler Frontotemporal Degener 63, 1–10., 2019 | 70* | 2019 |
| Characterization and use of the NSC‐34 cell line for study of neurotrophin receptor trafficking D Matusica, MP Fenech, ML Rogers, RA Rush Journal of neuroscience research 86 (3), 553-565, 2008 | 70 | 2008 |
| ProNGF mediates death of Natural Killer cells through activation of the p75NTR–sortilin complex ML Rogers, S Bailey, D Matusica, I Nicholson, H Muyderman, ... Journal of Neuroimmunology 226 (1-2), 93-103, 2010 | 61 | 2010 |
| Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor β do not account for the cell growth activity present in … DA Belford, ML Rogers, GL Francis, C Payne, FJ Ballard, C Goddard Journal of endocrinology 154 (1), 45-55, 1997 | 47 | 1997 |
| Identification of fibroblast growth factors in bovine cheese whey ML Rogers, DA Belford, GL Francis, FJ Ballard Journal of Dairy Research 62 (3), 501-507, 1995 | 43 | 1995 |
| CD 271 (P75 neurotrophin receptor) M Rogers, A Beare, H Zola, RA Rush Journal of Biological Regulators and Homeostatic Agents 22 (1), 1-6, 2008 | 36 | 2008 |
| Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy M Garcia-Montojo, S Fathi, G Norato, BR Smith, DB Rowe, MC Kiernan, ... Journal of the neurological sciences 423, 117358, 2021 | 34 | 2021 |
| Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice ML Rogers, I Atmosukarto, DA Berhanu, D Matusica, P Macardle, ... Journal of neuroscience methods 158 (1), 109-120, 2006 | 34 | 2006 |
| Choroid plexus transplants in the treatment of brain diseases SJM Skinner, MS Geaney, R Rush, ML Rogers, DF Emerich, CG Thanos, ... Xenotransplantation 13 (4), 284-288, 2006 | 32 | 2006 |
| Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment D Matusica, F Alfonsi, BJ Turner, TJ Butler, S Shepheard, ML Rogers, ... Journal of Cell Science 129 (3), 517-530, 2016 | 30 | 2016 |
| Removal of p75 neurotrophin receptor expression from cholinergic basal forebrain neurons reduces amyloid-β plaque deposition and cognitive impairment in aged APP/PS1 mice L Qian, MR Milne, S Shepheard, ML Rogers, R Medeiros, EJ Coulson Molecular neurobiology 56, 4639-4652, 2019 | 28 | 2019 |
Stephanie ShepheardFlinders UniversityVerified email at flinders.edu.au
